Literature DB >> 32813543

On Happy Hypoxia and on Sadly Ignored "Acute Vascular Distress Syndrome" in Patients with COVID-19.

Vincent Jounieaux1, Daniel Oscar Rodenstein2, Yazine Mahjoub1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32813543      PMCID: PMC7706160          DOI: 10.1164/rccm.202006-2521LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
To the Editor: We read with great interest the article by Tobin and colleagues (1) on the issue of silent hypoxemia, which is also known as happy hypoxia, and found it to be a nice review of physiologic mechanisms of dyspnea. The authors refer to the definitions and mechanisms of dyspnea in relation to blood gases, pulmonary insults, age, and disease. They also discuss the definitions and effects of hypoxia, the inaccuracies of pulse saturation, and the properties of the oxygen dissociation curve as well as the mechanisms of hypoxemia in patients with coronavirus disease (COVID-19). We agree that all the physiologic concepts recalled by Tobin and colleagues might, in isolation or together, contribute to a blunted ventilatory response to low levels of PaO and to its corollary subjective feeling of normality or the absence of dyspnea. Among these various factors, we do not believe that the poor correlation between oxygen saturation and arterial partial pressure at low levels of saturation can explain happy hypoxia because, as shown in the vignettes of their paper, patients have not only low oxygen saturation as measured by pulse oxymetry (SpO) values but also very low levels of PaO (which, according to Tobin and colleagues’ Figure 1, should have led to ventilation levels well above 20 L/min), yet they consistently denied any difficulty with breathing. Similarly, although age and diabetes have a known blunting effect on the ventilatory response to hypoxia, many patients with happy hypoxia are in their 50s or 60s, wherein age effects are not expected to be great, and are not diabetic. Similarly, we would add that if dyspnea is subjective, e levels of more than 20 L/min require obvious use of accessory muscles and visible increases in respiratory frequency that patients with happy hypoxia do not show. We would like to advance that the main reason for the phenomenon of happy hypoxia is the presence of hypocapnia. We have shown several years ago that hypocapnia has such a powerful braking effect on the respiratory center that it can completely abolish any response to repeated exposure to very low SpO2 levels in normal subjects (2). We see no reasons why happy hypoxia should be limited, as Tobin and colleagues claim, to patients without hypocapnia. By the way, hypocapnia and its consequent alkalosis would tend to shift the oxygen dissociation curve to the left, counteracting the rightward shift due to fever. As to the reasons for hypocapnic hypoxia without dyspnea, there is one that Tobin and colleagues do not mention and that we believe offers the best explanation, as follows: the presence of a right-to-left intrapulmonary shunt (3). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to induce vascular proliferation in the lungs demonstrated both in anatomic and radiologic studies (4, 5). We have demonstrated a late right-to-left intrapulmonary shunt by contrast enhanced echocardiography in one patient with COVID-19 without radiologic lung lesions (unpublished observation). This right-to-left shunt will induce hypoxia, leading to a normal increase in ventilation. However, in face of a shunt, hyperventilation will not increase PaO but will certainly decrease PaCO, with CO2 being more diffusible than O2. Thus, hypocapnia would develop, abolishing any further increase in ventilation and explaining the absence of enhanced respiratory efforts and, therefore, of dyspnea. This, we contend, is the initial insult of SARS-CoV-2 that has prompted us to coin the acronym “AVDS” for acute vascular distress syndrome (6). When lung lesions become prominent, showing either ground-glass opacities or consolidations, hypoxia could worsen but hypocapnia would lessen, with the consequent normalization of PaCO and the appearance of feelings of difficult breathing. In conclusion, we believe it is now time to consider the intrapulmonary shunt as the key factor in patients with COVID-19 that accounts for both the presence of hypoxia and the absence of dyspnea in many of them.
  5 in total

1.  Effects of hypocapnic hyperventilation on the response to hypoxia in normal subjects receiving intermittent positive-pressure ventilation.

Authors:  Vincent Jounieaux; Veronica F Parreira; Genevieve Aubert; Myriam Dury; Pierre Delguste; Daniel O Rodenstein
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

2.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

3.  Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT.

Authors:  Min Lang; Avik Som; Dexter P Mendoza; Efren J Flores; Nicholas Reid; Denston Carey; Matthew D Li; Alison Witkin; Josanna M Rodriguez-Lopez; Jo-Anne O Shepard; Brent P Little
Journal:  Lancet Infect Dis       Date:  2020-04-30       Impact factor: 25.071

4.  Severe Covid-19 disease: rather AVDS than ARDS?

Authors:  Yazine Mahjoub; Daniel Oscar Rodenstein; Vincent Jounieaux
Journal:  Crit Care       Date:  2020-06-11       Impact factor: 9.097

5.  Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.

Authors:  Martin J Tobin; Franco Laghi; Amal Jubran
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

  5 in total
  9 in total

1.  Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study.

Authors:  Prashant Sirohiya; Arunmozhimaran Elavarasi; Hari Krishna Raju Sagiraju; Madhusmita Baruah; Nishkarsh Gupta; Rohit Kumar Garg; Saurav Sekhar Paul; Brajesh Kumar Ratre; Ram Singh; Balbir Kumar; Saurabh Vig; Anuja Pandit; Abhishek Kumar; Rakesh Garg; Ved Prakash Meena; Saurabh Mittal; Saurabh Pahuja; Nupur Das; Tanima Dwivedi; Ritu Gupta; Sunil Kumar; Manisha Pandey; Abhinav Mishra; Karanvir Singh Matharoo; Anant Mohan; Randeep Guleria; Sushma Bhatnagar
Journal:  Lung India       Date:  2022 May-Jun

Review 2.  The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.

Authors:  Marco Chilosi; Venerino Poletti; Claudia Ravaglia; Giulio Rossi; Alessandra Dubini; Sara Piciucchi; Federica Pedica; Vincenzo Bronte; Giovanni Pizzolo; Guido Martignoni; Claudio Doglioni
Journal:  Mod Pathol       Date:  2021-04-21       Impact factor: 8.209

3.  AVDS should not dethrone ARDS.

Authors:  Yazine Mahjoub; Daniel Rodenstein; Vincent Jounieaux
Journal:  Crit Care       Date:  2021-11-18       Impact factor: 9.097

4.  Clinical Outcomes of Early Versus Late Intubation in COVID-19 Patients.

Authors:  Ali Al-Tarbsheh; Woon Chong; Jozef Oweis; Biplab Saha; Paul Feustel; Annie Leamon; Amit Chopra
Journal:  Cureus       Date:  2022-01-27

5.  Case Reports: Bronchial Mucosal Vasculature Is Also Involved in the Acute Vascular Distress Syndrome of COVID-19.

Authors:  Vincent Jounieaux; Damien Basille; Bénédicte Toublanc; Claire Andrejak; Daniel Oscar Rodenstein; Yazine Mahjoub
Journal:  Front Med (Lausanne)       Date:  2021-11-30

6.  Silent hypoxia is not an identifiable characteristic in patients with COVID-19 infection.

Authors:  Nicholas Russell Plummer; Andrew Fogarty; Dominick Shaw; Timothy Card; Joe West; Colin Crooks
Journal:  Respir Med       Date:  2022-04-26       Impact factor: 4.582

7.  The importance of lung hyperperfusion patterns in COVID-19-related AVDS.

Authors:  Vincent Jounieaux; Yazine Mahjoub; Isabelle El-Esper; Daniel Oscar Rodenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-11       Impact factor: 9.236

Review 8.  Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities.

Authors:  Woon H Chong; Biplab K Saha; Amit Chopra
Journal:  Heart Lung       Date:  2021-05-29       Impact factor: 2.210

Review 9.  Non-invasive Respiratory Support in COVID-19: A Narrative Review.

Authors:  Manel Luján; Javier Sayas; Olga Mediano; Carlos Egea
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.